Biocryst Pharmaceuticals (BCRX) Return on Assets [ROA] (2011 - 2026)
Biocryst Pharmaceuticals (BCRX) reported Return on Assets [ROA] of -75.21% for Q2 2026, down 67.59 percentage points from -7.62% a year earlier but up 18.33 percentage points from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Biocryst Pharmaceuticals posted Return on Assets [ROA] of 52.53%, up 70.18 percentage points from FY2024.
- Return on Assets [ROA] has increased for three consecutive years, with a five-year change of +124.22 percentage points (FY2020 to FY2025).
- By year, Return on Assets [ROA] came in at -17.65% in FY2024 (+24.82 pp), -42.46% in FY2023 (+0.96 pp), -43.42% in FY2022 (-3.53 pp) and -39.89% in FY2021 (+31.80 pp).
- Five-year quarterly Return on Assets [ROA] spans a low of -93.54% in Q1 2026 and a high of 54.94% in Q4 2025.
- Year over year, Return on Assets [ROA] gained in six of the last eight quarters, with an average year-over-year change of +5.76 percentage points.
- The high point for year-over-year Return on Assets [ROA] in five years was Q4 2025 (a gain of 73.05 percentage points); the low point was Q1 2026 (a drop of 82.52 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -93.54% (Q1 2026), 54.94% (Q4 2025) and -1.94% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Biocryst Pharmaceuticals | 2.13 Bn | 1.05 Bn | 214.41 Mn | -75.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -75.21% |
| Mar 31, 2026 | -93.54% |
| Dec 31, 2025 | 54.94% |
| Sep 30, 2025 | -1.94% |
| Jun 30, 2025 | -7.62% |
| Mar 31, 2025 | -11.02% |
| Dec 31, 2024 | -18.11% |
| Sep 30, 2024 | -25.70% |
| Jun 30, 2024 | -31.04% |
| Mar 31, 2024 | -42.36% |
| Dec 31, 2023 | -43.57% |
| Sep 30, 2023 | -44.90% |
| Jun 30, 2023 | -46.69% |
| Mar 31, 2023 | -42.70% |
| Dec 31, 2022 | -44.58% |
| Sep 30, 2022 | -36.17% |
| Jun 30, 2022 | -40.38% |
| Mar 31, 2022 | -34.77% |
| Dec 31, 2021 | -43.11% |
| Sep 30, 2021 | -82.41% |
API Access
Biocryst Pharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();